| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 06/15/2011 | EP2332962A1 Cyclopenta[g]quinazoline compounds for use in the treatment of inflammatory or allergic conditions |
| 06/15/2011 | EP2332567A1 Combination therapy for treating protein deficiency disorders |
| 06/15/2011 | EP2332565A1 Low dose methods for treating disorders in which TNFalpha activity is detrimental |
| 06/15/2011 | EP2332540A1 Administration of ranolazine for the treatment of diabetes |
| 06/15/2011 | EP1622616B1 Inhibitors of akt activity |
| 06/15/2011 | CN101065118B A composition comprising at least 3 different diols |
| 06/14/2011 | US7960432 Compositions and products containing S-equol, and methods for their making |
| 06/14/2011 | US7960355 Compositions and methods for the modulation of the expression of B7 protein |
| 06/14/2011 | US7960350 Comprises N-alpha-acetyl-L-histidine; kits; droppers |
| 06/14/2011 | US7960133 Methods of diagnosing leiomyoma by measuring catechol-O-methyltransferase |
| 06/14/2011 | US7959951 Nitric oxide and its biomedical significance |
| 06/14/2011 | US7959927 Mycoplasma hyopneumoniae bacterin vaccine |
| 06/14/2011 | CA2512987C 17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators |
| 06/09/2011 | WO2003043587A9 Recovery of recombinant human parainfluenza virus type 1 (hpiv1) from cdna |
| 06/09/2011 | US20110135799 Thickened beverages for dysphagia |
| 06/09/2011 | US20110135798 Microcrystalline Cellulose Compositions |
| 06/09/2011 | US20110135687 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 06/09/2011 | US20110135597 Uses of Mammalian Cytokine; Related Reagents |
| 06/09/2011 | US20110135568 Thickened beverages for dysphagia |
| 06/08/2011 | EP2330213A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 06/08/2011 | EP2330129A2 Anti-TNF antibodies, compositions, methods and uses |
| 06/08/2011 | EP2329832A1 Protein formulation |
| 06/08/2011 | EP2329831A2 Stimulation of hair growth by Ginko biloba flavanoids |
| 06/08/2011 | EP1694271B1 Fsh glycosylation mutant |
| 06/08/2011 | EP1485127B1 Administration of agents for the treatment of inflammation |
| 06/08/2011 | CN1852722B Use of insulin and myristoylation PKC alpha Pseudo substrate in preparing medicine for healing skin wound |
| 06/08/2011 | CN1816544B Immunosuppressant compounds and compositions |
| 06/08/2011 | CN1749252B Compounds useful to treat retroviral infections |
| 06/08/2011 | CN1700918B N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase |
| 06/08/2011 | CN101090702B Topical composition |
| 06/07/2011 | US7956232 Reactive nanoparticles as destructive adsorbents for biological and chemical contamination |
| 06/07/2011 | US7956088 2-Pyrrolidone, 2-furanone, or 2-thiophenone derivatives; bactericides, fungicides; antiinflammatory, antiulcer, anticarcinogenic, and antiproliferative agents; pancreatitis, atherosclerosis, glomerulitis, organ transplant rejection; dyspepsia, gingivitis and periodontitis |
| 06/07/2011 | US7956047 Stimulating formation of collagen based extracellular matrix; fibrillogenesis agonism; wound healing |
| 06/07/2011 | US7955849 Method of enriching a mammalian cell population for mesoderm cells |
| 06/07/2011 | US7955626 Method for enhancing the DNA repair process, treating disorders associated with the DNA repair process, enhancing antitumor response and treating disorders associated with anti-tumor response in mammals by administering purified quinic acid and/or carboxy alkyl ester |
| 06/07/2011 | US7954491 Low dose pharmaceutical powders for inhalations |
| 06/02/2011 | US20110130570 Novel Form of S-Omeprazole |
| 06/02/2011 | US20110130349 Compounds and Methods for Treating Toll-Like Receptor 2-Related Diseases and Conditions |
| 06/02/2011 | US20110129482 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 06/02/2011 | US20110129448 Methods to mobilize progenitor/stem cells |
| 06/01/2011 | EP2327401A2 Retinoid Replacements and Opsin Agonists and Methods for the Use Thereof |
| 06/01/2011 | EP2327400A2 Retinoid Replacements and Opsin Agonists and Methods for the Use Thereof |
| 06/01/2011 | EP1622914B1 New piperidinylamino-thieno[2,3-d] pyrimidine compounds |
| 06/01/2011 | CN1805755B Therapeutic use of anti- CS1 antibodies |
| 06/01/2011 | CN102079746A Pyrazolo-quinazoline derivatives,process for their preparation and their use as kinase inhibitors |
| 05/31/2011 | US7951921 Multivalent carriers of bi-specific antibodies |
| 05/31/2011 | US7951817 Pyridomorphinans, pyridazinomorphinans and use thereof |
| 05/31/2011 | US7951775 Methods and pharmaceutical compositions for GnRH-I and GnRH-II modulation of T-cell activity, adhesion, migration and extravasation |
| 05/31/2011 | US7951360 Mutant interleukin-2 (IL-2) polypeptides |
| 05/31/2011 | CA2521182C Composition for improving cognition and memory |
| 05/31/2011 | CA2468747C Use of pramipexole to treat amyotrophic lateral sclerosis |
| 05/26/2011 | US20110124691 Organic Compounds |
| 05/26/2011 | US20110124645 Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses |
| 05/26/2011 | US20110124611 Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
| 05/26/2011 | US20110124583 Methods and Compositions for the Treatment of Gastrointestinal Disorders |
| 05/26/2011 | US20110123450 Macrocyclic cyanine and indocyanine bioconjugates provide improved biomedical application |
| 05/25/2011 | EP2325651A2 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 05/25/2011 | EP2325317A1 Receptor nucleic acids and polypeptides |
| 05/25/2011 | EP2325202A1 Uses of interferons with altered spatial structure |
| 05/25/2011 | EP2324823A2 Retinoid replacements and opsin agonists and methods for the use thereof |
| 05/25/2011 | CN1845757B Use of cell factor mixture in preparing medicine for pre-sensitizing cancer and pharmaceutical composition for treating cancer |
| 05/25/2011 | CN101062037B Process for their preparation of thioxanthine derivatives, their use |
| 05/24/2011 | US7947665 LPA receptor agonists and antagonists and methods of use |
| 05/24/2011 | US7947313 Compositions for diabetes treatment and prophylaxis |
| 05/24/2011 | US7947312 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals |
| 05/24/2011 | CA2506159C Fat regulation |
| 05/19/2011 | US20110118294 Intranasal Opioid Compositions |
| 05/19/2011 | US20110118213 Compounds and methods for delivery of prostacyclin analogs |
| 05/19/2011 | US20110117049 Methods and Compositions for Modulating Adipocyte Function |
| 05/18/2011 | EP2322545A1 Analogues of GLP-1 |
| 05/18/2011 | EP2322513A2 Intermediates |
| 05/18/2011 | EP2322210A1 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 05/18/2011 | EP2322208A2 Bowman-Birk inhibitor compositions for treatment of muscular atrophy and degenerative muscle disease |
| 05/18/2011 | EP1581221B1 Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists |
| 05/18/2011 | CN1798831B Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains |
| 05/18/2011 | CN102060843A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 05/18/2011 | CN102058597A Use of flibanserin in the treatment of sexual disorders |
| 05/18/2011 | CN101123871B Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production |
| 05/17/2011 | US7943640 3-Fluoro-2-(2-methylsulfanyl-phenyl)-quinolin-4-yl]-pyridin-4-yl-amine; modulating transforming growth factor (TGF) - beta; fibroproliferative diseases or diseases associated with fibrosis; cardiovascular, urogenital and gastrointestinal disorders; antihypotensive, -arthritic agents; angioplasty |
| 05/17/2011 | US7943616 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders |
| 05/17/2011 | US7943595 Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative |
| 05/17/2011 | US7943166 transient receptor potential vanilloid-1 (TRPV1) such as capsaicin; for reducing nociceptive nerve fiber function; topical application |
| 05/17/2011 | US7943153 Vaccines for Mycoplasma bovis and methods of use |
| 05/17/2011 | US7943130 Methods and compositions relating to CCR5 antagonist, IFN-γ and IL-13 induced inflammation |
| 05/17/2011 | CA2688934C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 05/17/2011 | CA2470365C 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
| 05/17/2011 | CA2333582C Nicotine immunogen |
| 05/12/2011 | US20110111482 High Viscosity Xanthan Polymer Preparations |
| 05/12/2011 | US20110110938 Compositions and methods for the treatment of immune related diseases |
| 05/11/2011 | EP2319532A1 Recombinant dengue virus containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 3, or 4 |
| 05/11/2011 | EP2319318A2 Methods of identifying compounds that target TRNA splicing endonuclease and uses of said compounds as anti-proliferative agents |
| 05/11/2011 | EP1606297B1 Preparation of high viscosity xanthan polymers |
| 05/11/2011 | EP1456398B1 Recovery of recombinant human parainfluenza virus type 1 (hpivi) from cdna |
| 05/11/2011 | CN101254302B Treatment of autoimmune diseases with antagonists which bind to b cell surface markers |
| 05/10/2011 | US7941211 Potentiation with zeaxanthin; imparting yellowish color prior to administering light activated drugs; wet (exudative) macular degeneration |
| 05/10/2011 | US7939549 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof |
| 05/10/2011 | US7939519 Immunosuppresant compounds and compositions |
| 05/10/2011 | US7939491 Method for reducing the likelihood of implantation failure during assisted reproduction in a subject |
| 05/10/2011 | US7939468 Methods of identifying compounds that target tRNA splicing endonuclease and uses of said compounds as anti-proliferative agents |
| 05/10/2011 | US7939318 Flexible vaccine assembly and vaccine delivery platform |